Fluorouracil in oral and maxillofacial surgery
5-Fluorouracil (5-FU) is an antimetabolite chemotherapeutic agent that interferes with DNA synthesis in rapidly proliferating cells, leading to apoptosis and inhibition of cellular proliferation.…
Ingredients are a key player in the world of oral and maxillofacial pathology. Many times, these ingredients play a critical role in helping to diagnose and treat diseases and conditions related to dental science. Ingredients in oral care products can often cause a condition called mucositis, or inflammation of the mucous membranes of the mouth and throat. Mucositis can be caused by poor hygiene, overuse of certain products, or infections such as Oral thrush. Symptoms range from mild to severe and often involve a burning sensation, soreness, and irritation in the mouth. Denture stomatitis is also a type of oral and maxillofacial pathology related to the use of dentures. This condition occurs when bacteria, fungus, or other particles build up in the dentures, causing inflammation, ulcers, and soreness. In many cases, denture stomatitis can be controlled through good oral hygiene and by avoiding foods that contain high levels of acid like citrus fruits and tomatoes. Infections are also common in the world of oral and maxillofacial pathology. Dental infections such as periodontal disease and tooth decay can lead to pain, swelling, redness, and other symptoms. In some cases, these infections can be addressed with antibiotics, or surgery may be necessary to remove the infection. Oral and maxillofacial pathology can also encompass more serious medical conditions such as oral cancer and jaw deformities. In many cases, surgical intervention is needed to treat these conditions. Medications and radiation therapy may also be required to help provide an effective treatment plan. In conclusion, ingredients in oral care products, infections, and other medical conditions can all contribute to oral and maxillofacial pathology. Recognizing the symptoms and causes of these conditions can help to provide early treatment and prevent further damage and harm. Proper oral hygiene and diet can also play a role in keeping these conditions under control.
5-Fluorouracil (5-FU) is an antimetabolite chemotherapeutic agent that interferes with DNA synthesis in rapidly proliferating cells, leading to apoptosis and inhibition of cellular proliferation.…
Introduction: Florid Cemento-Osseous Dysplasia (FCOD) is a benign fibro-osseous lesion that primarily affects the tooth-bearing regions of the jaws. It is often detected incidentally during…
Background : A complex odontoma is a benign odontogenic tumor of the jaw, consisting of a disorganised mass of dental tissue. Aetiology remains unclear and there have been reports of a potential…
Brown tumors are a rare non-neoplastic bone lesion resulting from an abnormal bone metabolism such as the increase of osteoclastic activity and fibroblastic proliferation. Usually, they are found in…
Angiolipoma is a benign tumor clinically similar to a lipoma, but its degree of vascularization is much higher when examined microscopically. It is formed by fatty acids and vascular elements. It…
Fibrous hyperplasia is a lesion characterized by the formation of epithelial tissue and fibrous connective tissue in response to chronic trauma or local irritation. It is often located in regions…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Oral and maxillofacial pathology work, reviewed by the scientific committee.
Meet dentists, oral-health researchers, and clinical leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Oral and maxillofacial pathology research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Oral and maxillofacial pathology track is a dedicated stream within Dental 2027 covering the latest research, clinical innovation, and best practice in Oral and maxillofacial pathology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Educators, doctoral students, and dentists, oral-health researchers, and clinical leaders with an interest in Oral and maxillofacial pathology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. Dental 2027 is a hybrid conference — attend the Oral and maxillofacial pathology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.